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Abstract
Background—The men having sex with men (MSM) population has become one of major risk 
groups for HIV-1 infection in China. However, the epidemiological patterns, function of the env 
genes, and autologous and heterologous neutralization activity in the same MSM population have 
not been systematically characterized.
Methods—The env gene sequences were obtained by the single genome amplification (SGA). 
The time to the most recent common ancestor (tMRCA) was estimated for each genotype using 
the Bayesian MCMC approach. Coreceptor usage was determined in NP-2 cells. Neutralization 
was analyzed using Env pseudoviruses in TZM-bl cells.
Results—We have obtained 547 full-length env gene sequences by SGA from 30 acute/early 
HIV-1-infected individuals in the Beijing MSM cohort. Three genotypes (Subtype B, CRF01_AE, 
and CRF07_BC) were identified and 20% of the individuals were infected with multiple 
transmitted/founder (T/F) viruses. The tight clusters of the MSM sequences regardless of 
geographic origins indicated nearly exclusive transmission within the MSM population and 
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limited number of introductions. The tMRCA for each genotype was 10-15 years after each was 
first introduced in China. Disparate preferences for coreceptor usages among three genotypes 
might lead to the changes in percentage of different genotypes in the MSM population over time. 
The genotype-matched and -mismatched neutralization activity varied among the three genotypes.
Conclusions—Identification of unique characteristics for transmission, coreceptor usage, 
neutralization profile and epidemic patterns of HIV-1 is critical for the better understanding of 
transmission mechanisms, development of preventive strategies, and evaluation of vaccine 
efficacy in the MSM population in China.
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Introduction
While heterosexual transmission is the primary mode for HIV-1 transmission in China, 
homosexual transmission accounts for a large portion of infection cases 1,2. The proportion 
of reported cases from the men who have sex with men (MSM) population alarmingly 
increased over the years, from 0.4% before 2005 to 13.7% in 2011 3. Thus, it is essential to 
study the MSM population in order to understand epidemiological patterns of transmission, 
unique biological characteristics, pathogenesis, and potential vaccine strategies to better 
control its continuous spread.
Analysis of HIV-1 sequences from acute infection using the single genome amplification 
(SGA) method showed that approximately 20% of heterosexual infections are established by 
multiple transmitted/founder (T/F) viruses 4,5. A recent study demonstrated that individuals 
infected with subtype B viruses in the MSM cohort in the United States had a significantly 
higher frequency (36%) of infections with multiple T/F viruses 6, suggesting that higher risk 
sexual activity could lead to infections by multiple T/F viruses, which might have a 
significant impact on disease progression 7-9. Since viral genotypes, epidemiological factors 
and social behaviors differ greatly between the MSM populations in China and US, it is 
important to understand if MSM who were infected with different genotypes in China are 
infected with multiple T/F viruses at a higher percentage than those infected through 
heterosexual transmission.
Many viruses from MSM cohorts have been studied in China. However, most of the 
sequences were small partial sequences and only a few complete functional env sequences 
have been characterized. No T/F env sequences have been fully characterized from the 
MSM cohorts in China. Therefore, the biological characteristics of the env genes from MSM 
have not been well studied. Furthermore, whether cross-clade neutralization can be elicited 
among different genotypes in the same MSM cohort is not known. Thus, genetic and 
phenotypic analysis of multiple genotypes in the same MSM cohort has not been 
systematically performed. We recently have established an acute MSM infection cohort in 
Beijing, China 10. Since the majority of infections were identified at early Fiebig stages in 
this cohort, we determined the number of T/F viruses in most of the subjects, the timing for 
introduction of each genotype into the MSM population, coreceptor preference of different 
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genotypes, and neutralization susceptibility to genotype-matched and -mismatched sera. The 
results obtained in this study may provide a foundation for a better understanding of HIV 
transmission in the MSM population and improve prevention programs in the future.
Materials and Methods
Plasma samples
Plasmas were obtained from 30 subjects with acute/early HIV-1 infection between 2007 and 
2008 at You'an hospital in Beijing, China. The written consent was obtained from all 
patients who participated in the study, and the study was approved by the ethics committee 
of You'an Hospital and the Duke University Institutional Review Board. Fiebig stages were 
determined by measurement of viral loads by real-time PCR and HIV-1 specific antibodies 
by EIA and Western Blot as previously described5,11. Nine samples were at Fiebig stage I/II, 
six at Fiebig stage IV, 11 at Fiebig stage V, and four at Fiebig stage VI.
Analysis of the env gene sequences
Viral RNA was extracted from 200 μl of plasma using Pure Link viral RNA/DNA mini kit 
(Invitrogen, Carlsbad, CA). The reverse transcription and single genome amplification 
(SGA) of the 3′half genome were performed with the primers and conditions as previously 
described 12. The sequence analysis, phylogenetic tree and Highlighter plot analyses were 
carried as reported in our previous study13.
Molecular evolution clock analysis
The rates of evolutionary substitution and the divergence times for CRF01_AE, CRF07_BC, 
and subtype B were estimated using the Bayesian Markov Chain Monte Carlo (MCMC) 
approach available in the BEAST v1.5.4 package 14,15. Each MCMC analysis was run for 20 
or 30 million steps and sampled every 10,000 states. Posterior probabilities were calculated 
with a 10% burn-in and checked for convergence using Tracer v1.5. The maximum clade 
credibility tree was generated using Tree Annotator v1.5.4 available in BEAST and Fig Tree 
1.3.1 was used for visualization of the annotated trees 16.
Determination of coreceptor usage
Coreceptor usage was determined in NP-2 cells expressing CD4 along with CCR5, CXCR4, 
or other coreceptors using Env pseudoviruses as previously described 13,17. Virus replication 
was determined by measuring p24 at day 0 and day 3 using the Alliance HIV-1 p24 Antigen 
ELISA kit (PerkinElmer, Boston, MA).
Neutralization assays
Neutralization activity was measured in a luciferase reporter system in TZM-bl cells as 
described previously 18,19. Plasma samples were heat-inactivated at 56°C for1 h and were 
then diluted at a 1:3 serial dilution starting at 1:20. The diluted plasma samples in duplicates 
were incubated with pseudoviruses for 1 h at 37°C and then used to infect TZM-bl cells. The 
50% inhibitory dose (ID50) was defined as the plasma dilution at which relative 
luminescence units (RLU) were reduced by 50% compared to RLU in virus control wells 
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after subtraction of background RLU in cell control wells. A response was considered 
positive for neutralization if the ID50 titer was >1:20 dilution.
Statistical analysis
Statistical analyses were performed using SAS v9.3 (SAS Institute Inc., Cary, NC). The 
coreceptor usage data were analyzed using a Wilcoxon (Mann-Whitney) rank sum test. The 
analysis of the autologous neutralization data in each genotype over time was performed 
using a linear mixed effects model. The heterologous neutralization data was analyzed in 
two by two blocks using Fisher's exact test.
Nucleotide Sequence Accession numbers
The Gen Bank accession numbers for all sequences generated in this study are KM217583-
KM218333.
Results
The majority of individuals in the MSM cohort were infected with single T/F viruses
A total of 547 env SGA sequences were derived from 30 individuals (an average of 18 per 
person) in this MSM cohort (Table 1). Over 20 SGAs were obtained from 17 individuals. 
Fewer SGAs (2-18) were generated from other 13 individuals, due to the low viral loads 
and/or limited sample volumes for the screening samples. Phylogenetic tree analysis showed 
that all sequences from each individual clustered tightly together (Figure S1). Two T/F 
viruses were identified in three individuals (BJOX25, BJOX011 and BJOX07), while three 
T/F viruses were detected in BJOX28 (Figure 1A). The T/F viral sequences could be 
unambiguously inferred in 20 individuals from whom at least sixteen SGA sequences. Thus 
20% (4/20) MSM individuals in this cohort were infected with more than one T/F virus. The 
other 10 individuals were not included for analysis because the numbers of T/F viruses in 
these individuals could not be unequivocally inferred due to higher levels of genetic 
variability (Fiebig stages V or later) or small numbers of SGAs (<15).
MSM sequences in China formed tight clusters within each genotype
To understand the genetic relationship between the newly characterized MSM sequences 
with those previously reported in China, a phylogenetic tree was constructed with one T/F or 
representative env gene sequence from each individual and all full-length env sequences 
from China available in the HIV-1 sequence database (http://www.hiv.lanl.gov). The 
phylogenetic tree analysis showed that 13 (43.3%) were CRF01_AE, 11 (36.7%) were 
subtype B, and 6 (20.0%) were CRF07_BC (Figure 1B and Table 1). Interestingly, all new 
MSM sequences were found in four closely related clusters: two in CRF01_AE, one in 
CRF07_BC and one in subtype B. Examination of the transmission routes for the other 
sequences clustered with the newly obtained sequences showed that nearly all of them were 
MSM derived (Figure 1B), strongly suggesting that the MSM sequences in China were 
highly related to each other. Analysis of additional shorter env sequences from China 
confirmed that the vast majority of the MSM sequences in China were tightly clustered 
together (Figure S2). Analysis of the geographic origins of those viruses showed that they 
were from provinces geographically far from each other; south provinces (Guangdong, 
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Yunnan and Hainan), north province (Liaoning), west province (Xinjiang), east province 
(Jiangsu) and central provinces (Hebei, Sichuan, Tianjin and Beijing) (Figure 1B and S2), 
similar to those recently reported by others 20-22. These results suggested that the majority of 
MSM viruses, irrespective of large geographic distances, shared the same most recent 
common ancestors (MRCAs).
CRF01_AE MSM sequences formed three independent clusters, of which clusters I and II 
were equally predominant while cluster III was only represented by one MSM sequence 
(09LNA379) (Figure 1B). CRF07_BC MSM sequences from this and other studies formed 
one tight cluster. Although subtype B MSM sequences were more divergent than CRF01 
and CRF07 sequences, they still tended to cluster together. Thai B′ sequence were much 
more predominant than US/Europe B sequences in China, but only one MSM env sequence 
was found to be B′. These results showed that only some subtypes or CRFs were introduced 
into the MSM population from the general HIV-1-infected population, irrespective of 
predominance of the genotypes in the general population. However, after the viruses were 
transmitted into the MSM population, they mainly spread within the MSM population nation 
wide.
We next sought to investigate how the newly characterized and previously reported MSM 
viral sequences related to viruses in the general population in Beijing. Since there were only 
very few non-MSM sequences from Beijing available for analysis, we obtained partial env 
sequences from 31 non-MSM subjects from Beijing and compared them with the MSM 
sequences from the same city. Phylogenetic tree analysis showed that three genotypes from 
the MSM population had different relationships with viruses from the general HIV-1-
infected populations in Beijing. The subtype B MSM sequences intermingled with eight 
non-MSM viral sequences from Beijing in the phylogenetic tree (Figure S3A). However, all 
non-MSM subtype B sequences were within the large cluster formed by the MSM 
sequences, suggesting that they might be the result of transmission from the MSM 
population in Beijing. This is in good agreement with results from the full-length env 
sequence analysis (Figures 1B and 2). CRF01_AE sequences from non-MSM subjects 
formed three clusters. In two clusters, MSM and non-MSM sequences intermingled in the 
phylogenetic tree (Figure S3B), suggesting that they became indistinguishable from each 
other after introduction from outside. It was also possible that there were on-going 
transmissions between the two populations. Both MSM and non-MSM CRF07_BC viruses 
generally intermingled with those from other cities (Figure S3C). However, more than two-
thirds of MSM CRF07_BC sequences formed a tight cluster with one non-MSM sequence 
and one sequence with unknown transmission route, suggesting that the viruses in this 
cluster resulted from a single introduction from the non-MSM population and had spread in 
the MSM population in Beijing. These results suggested that multiple transmissions 
occurred between MSM and non-MSM populations in Beijing but one introduction of 
CRF07_BC resulted in fast expansion in the Beijing MSM cohort. Since Beijing MSM 
CRF07_BC sequences clustered tightly with those from other cities (Figure 1B), it was 
likely that they would become one predominant genotype in the MSM population in the 
country. Although these results showed more frequent HIV-1 transmissions between MSM 
and non-MSM populations in Beijing, the majority of epidemic MSM sequences tended to 
Chen et al. Page 5
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
tightly cluster together, indicating that only a limited founder viruses was able to quickly 
spread and predominate the MSM population even in the city, possibly due to the exclusive 
relationship among partners within the MSM population. Some MSM CRF07_BC viruses 
were represented by single sequences. This indicated that they might represent independent 
introductions from the general population but might not become major epidemic strains. 
More sequences from MSM and non-MSM populations in other cities are required to 
confirm this epidemic pattern observed in Beijing. More importantly, the analysis of those 
sequences will reveal whether frequent transmissions between two populations can result in 
less distinction between viral sequences in MSM and non-MSM populations.
Estimation of the timing of introduction of different genotypes into the MSM cohort
The different clusters and various divergent levels of viruses indicated that HIV-1 was 
introduced into in the MSM cohort at different times. Since all complete env gene sequences 
from acute/early infection were obtained near the transmission time, we could accurately 
estimate the evolutionary rates and the most recent common ancestors (MRCA) of the 
different genotypes in the Beijing MSM cohort using the molecular clock approach 
implemented in BEAST v1.5.4 16. Both relaxed and strict molecular clocks showed similar 
evolutionary rates for subtype B, CRF01_AE and CRF07_BC env genes (Table S1). We 
then estimated the time to the most recent common ancestor (tMRCA) for each clusters 
(Table S1 and Figure 2), as previously described with the partial HIV-1 gene 
sequences 23-26. Among all available Europe/US subtype B sequences, the MSM sequences 
were highly divergent from each other (11.78% [5.70%-15.67%]), while the threenon-MSM 
sequences were less divergent (9.79% [6.70%-11.65%]). The tMRCA of the subtype B 
viruses in China was estimated at 1971 (95HPD: 1956-1983). All sequences that closest to 
the root were MSM sequences and they are more divergent from each other (14.48% 
[13.00%-16.05%]) that all those sequences within the cluster I (9.64% [4.37%-12.66%]), 
suggesting that subtype B was first introduced into the non-MSM population. Soon after 
that, all but one Beijing MSM sequences formed a tight cluster with these three non-MSM 
sequences. The tMRCA for this subtype B cluster was estimated at 1985 (95% HPD: 
1975-1993) (Figure 2A). These results indicated that the subtype B viruses were first 
introduced into the MSM population in 1971 in China and then they disseminated into the 
general population and into the MSM population in Beijing in 1985.
The CRF01_AE viruses were introduced into China at a later time point, with an estimated 
tMRCA at 1984 (95% HPD: 1977-1990). Both the CRF01_AE clusters were introduced into 
the MSM cohort roughly at the same time. The tMRCA for cluster I and II viruses were 
1994 (95% HPD; 1989-1998) and 1996 (95%HPD: 1992-1999), respectively (Figure 2B). 
The CRF07_BC viruses were only recently identified in China 27. The tMRCA of the 
CRF07_BC viruses in China was estimated at 1987 (95% HPD: 1980-1992). They were 
introduced into Beijing MSM cohort at 2002 (95% HPD: 2000-2004) (Figure 2C). These 
results demonstrated that different genotypes were introduced into the Beijing MSM cohort 
at different times, and all three genotypes were introduced about 10-15 years after the they 
were first introduced into China.
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Disparate coreceptor usages among different genotypes
In addition to the primary CCR5 and CXCR4, other coreceptors(CCR3, APJ, GPR15 and 
FPRL-1) are also used by HIV-113,28,29. CRF01_AE were mainly found in central Africa 
and Southeast Asia while CRF07_BE was primarily present in China 30,31. However, little 
was known for their coreceptor usage. To investigate the coreceptor tropism of the three 
genotypes in the Beijing MSM cohort, we determined their coreceptor usages in NP-2 cell 
lines. All viruses infected CCR5+ cells but only BJOX35 (B) and BJOX37 (CRF07_BC) 
infected CXCR4+ cells (Figure 3). In addition, BJOX35 also used APJ and FPRL-1, while 
BJOX37 used FPRL-1. Both showed typical branching as other subtype B and CRF07_BC 
sequences in the phylogenetic tree (Figure 1B). Examination of amino acid sequences in V3 
and other regions in both sequences did not reveal any unique signatures that differed from 
other subtype B and CRF07_BC sequences (data not shown). Subtype B viruses replicated 
significantly better in CCR5+ cells than CRF01_AE viruses (p=0.011). The subtype B 
viruses were most promiscuous for coreceptor usage as previously reported 29,32,33; most of 
them (7/11) used CCR3 while some used APJ (3/11) and FPRL-1 (3/11). All six CRF07_BC 
viruses infected FPRL-1+ cells and replicated significantly better than the subtype B and 
CRF01_AE viruses (p=0.001 and p<0.001, respectively). None of CRF07_BC viruses used 
CCR3, APJ or GPR15. Interestingly, CRF01_AE viruses did not use any of those 
coreceptors other than CCR5, except one CRF01_AE virus (BJOX09) infected FPRL-1+ 
cells. Although GPR15 was often used by someHIV-1 strains 13,33,34, our results showed 
that no viruses in this cohort utilized it for infection, suggesting that different genotypes 
might affect the GPR15 tropism. Two and three T/F Env pseudoviruses generated from 
BJOX25 and BJOX28, respectively, did not show differences in coreceptor tropisms (data 
not shown). These results demonstrated that viruses in the Beijing MSM cohort could infect 
cells through CCR5, but they had different preferences for other coreceptors.
Autologous and heterologous neutralization among different genotypes
Since three different genotypes were identified in this MSM cohort, we first sought to 
investigate whether the development of autologous neutralization was different among them. 
The Env pseudoviruses were generated with the T/F or one representative env genes from 25 
subjects for whom longitudinal plasma samples were collected (more three time points) and 
their neutralization susceptibility to autologous plasma (up to 90 weeks of infection) was 
determined. The day post infection was estimated for each individual according to the Fiebig 
stage 11,35. Nineteen subjects developed autologous nAbs against autologous viruses (Figure 
4A). No autologous nAbs were detected in five subjects (BJOX28, BJOX35, BJOX47, 
BJOX19 and BJOX27). The autologous Abs were detected as early as day 103 in BJOX25 
and as late as day 533 in BJOX03. Multiple T/F viruses were identified in four subjects 
(Figure 1A). We determined the neutralization susceptibility of all identified T/F env genes 
in BJOX25 (2) and in BJOX28 (3) to longitudinal autologous plasma samples. The 
susceptibility of two BJOX25 T/F Env pseudoviruses to autologous neutralization was 
different, while no autologous neutralization to any of three T/F Envs was developed in 
BJOX28 (Figure S4A). Since there was only one sequence representing the second T/F virus 
in BJOX07 and BJOX11 (Figure 1A), T/F sequences could not be inferred and studied. 
Subjects infected with subtype B and CRF01_AE viruses developed relatively high titers of 
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autologous nAbs between days 200 and 400, while only 3 out of 5 subjects infected with 
CRF07_BC viruses developed autologous nAbs (Figure 4A). However, the differences in 
the autologous nAbs titers were not statistically significant among genotypes.
We next determined whether nAbs in subjects infected with one genotype had different 
breadths of neutralization activities against other genotype viruses during the early infection 
stage. The one plasma sample with highest nAb titers from each individual and sufficient 
amounts was used to determine its cross-genotype neutralization potency for genotype-
matched and -mismatched pseudoviruses (Figure 4B). The CRF01_AE plasmas could 
neutralize 47% of heterologous CRF01_AE viruses, but neutralized significantly fewer 
subtype B viruses (11%; p<0.001) and CRF07_BC viruses (19%; p<0.001). CRF07_BC 
plasmas neutralized 33% of heterologous CRF07_BC viruses, only 15% of CRF01_AE 
viruses (p=0.093), and none of the subtype B viruses (p<0.001). Subtype B plasmas 
neutralized all three genotype viruses (subtype B, CRF01AE and CRF07_BC) at similar 
levels (15%-21%; p>0.38). Analysis of multiple T/F Env pseudoviruses form same 
individual (BJOX28 and BJOX25) showed similar cross neutralization susceptibility to 
heterologous plasma (Figure S4B). These results showed that the development of nAbs that 
could neutralize genotype-matched and -mismatched viruses varied among individuals 
infected with different genotype viruses.
Discussion
By genetically and phenotypically characterizing the env genes from 30 acute/early HIV-1-
infectedindividuals in the Beijing MSM cohort, we have found that: single T/F viruses were 
the majority in the HIV-1-infected MSM individuals in this cohort; there was a 10-15 year 
delay for introduction of HIV-1 into the MSM population after their first introduction in 
China; limited genetic variation was observed in the MSM cohort across the county; the 
preference for usage of various secondary coreceptors varied among different genotypes; 
and disparate genotype-matched and mismatched neutralization activity developed among 
different genotypes. These results can have important implications for understanding HIV-1 
transmission mechanisms, developing means to control further introductions of new genetic 
variants into the MSM cohorts, and evaluating vaccine efficacy in this unique population.
A recent nationwide survey showed that CRF07_BC, CRF01_AE, CRF08_BE and “Thai” B
′ were most predominant (35.5%, 27.5%, 20.2% and 9.6%, respectively), “US/Europe” B 
was only present at 1%, and other genotypes were found in less than 1% of the population in 
China 30. However, only three genotypes (subtype B, CRF01_AE and CRF07_BC) were 
found in the current MSM cohort or in other studies20,36-38. These results indicate only 
limited independent introductions of HIV-1 into the MSM population, irrespective of the 
predominance of the genotypes in the general HIV-1-infected population in China. Future 
studies are warranted to investigate why predominant subtype B′ and CRF08_BC were 
rarely detected while rare “US/Europe” B in the general population was one of the 
predominant genotypes in the MSM population. Results from such studies may offer clues 
about the transmission mechanisms and lead to development means to prevent further 
introductions of new genetic variants into the MSM population.
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The molecular evolutionary clock analysis of the complete env gene showed that subtype B, 
CRF01_AE and CRF07_BC viruses were first introduced into China in 1971, 1984 and 
1987, respectively, while they were introduced into the Beijing MSM population in 1985, 
1994-1996, and 2002, respectively. These estimated tMRCAs were similar to those reported 
by others using different gene sequences 22-26,39. Interestingly, all three genotypes were 
introduced into the MSM populations in Beijing 10-15 years after it was first introduced in 
China. It will be important to understand the factors that determined this delay in future 
studies.
Analysis of all currently available HIV-1 sequences in China from the Los Alamos HIV 
Sequence Database showed the vast majority of MSM sequences, irrespective of geographic 
areas, formed closely related clusters. Similar results were reported with small sequence 
datasets when other parts of HIV-1 genome sequences were analyzed 20-22. This epidemic 
pattern was different from those in MSM populations in other countries, in which the MSM 
sequences intermingled with sequences from general HIV-1 infected individuals 40,41. This 
unique epidemic pattern indicated that only limited introductions of HIV-1 strains from the 
general population became predominant strains in the MSM populations in China and the 
close network resulted in transmission chains mainly among MSM, allowing spreading of 
the same viruses in all geographic regions across the country.
The number of the T/F env sequences could be unambiguously inferred from 20 individuals. 
The sequence analysis showed that four of those individuals were infected with 2 or 3 T/F 
viruses. Thus, 20% of individuals were infected with multiple T/F viruses, which was 
similar to the percentages for individuals infected with HIV-1 through heterosexual 
transmission4,5. However, this rate was only about half of the rate(36%) that was previously 
reported for the MSM individuals infected with subtype B viruses in the United States 6. 
This result suggested that the number of T/F viruses in MSM individuals could be affected 
by different genotypes, social behaviors, and races.
All newly characterized viruses in this MSM cohort could infect CCR5+ cells, while only 
two viruses (BJOX35 and BJOX37) infected CXCR4 cells. However, the three genotypes 
had different preferences for other coreceptors. Most subtype B viruses could infect CCR3+ 
cells while CRF01_AE and CRF07_BC did not. CRF01_AE viruses only used CCR5, not 
any of the other tested coreceptors. CRF07_BC viruses infected FPRL-1+ cells significantly 
better than Subtype B and CRF01_AE viruses. The disparate preferences for coreceptors 
usage between subtype B and CRF01_AE might play a role in the continuous decrease of 
CRF01_AE 21,30,38,39,42 and the gradual decrease of subtype B in the MSM population in 
China37,38.
The CRF01_AE plasmas neutralized a significantly higher percentage of heterologous 
CRF01_AE viruses than the subtype B and CRF07_BC viruses, while the subtype B 
plasmas similarly neutralized subtype B, CRF01_AE, and CRF07_BC viruses. Interestingly, 
none of the subtype B viruses could be neutralized by the CRF07_BC plasmas. These results 
demonstrated that the three genotypes elicited disparate cross-genotype neutralization 
activities, indicating that nAbs induced in individuals infected with one genotype viruses 
might not have optimal protection of super-infection of other subtypes or CRFs, especially 
Chen et al. Page 9
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
for those infected with CRF07_BC viruses. More recombinants among subtype B and 
CRF01_AE, CRF07_BC were recently identified 30,37,43,44, confirming super- and dual-
infections indeed occurred in the MSM population.
The limited genetic variation of each genotype in the MSM population across China and 
high incidence rate (2.6-10.2 per 100 person-years) in the MSM cohorts 45-47 make the 
MSM population ideal for evaluating vaccine efficacy. Since each genotype elicited 
genotype specific nAb responses, it is also possible to investigate how protective the 
immune responses elicited by one genotype vaccine can be against viruses of different 
subtypes or CRFs in future vaccine trials in this unique population.
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Figure 1. Genetic analysis of newly characterized MSM env sequences
(A) Phylogenetic tree and Highlighter plot analysis of the full-length env sequences. The env 
SGA sequences from each of the individuals who were infected with two or three T/F 
viruses were subjected to phylogenetic tree and Highlighter plot analysis. The neighbor-
joining trees were constructed using the neighbor-joining method and the Kimura two-
parameter model. The scale bar represents 0.0005 nucleotide substitutions per site. The 
Highlighter plot was done using the online tool (http://www.hiv.lanl.gov/content/sequence/
HIGHLIGHT/highlighter_top.html). (B) Phylogenetic relationship of the full-length env 
sequences from the MSM cohort in Beijing and other cities. The phylogenetic tree was 
constructed with the newly characterized env sequences and all env sequences in China 
available from the Los Alamos HIV-1 Sequencer Database. The scale bar represents 0.02 
nucleotide substitutions per site. The subtype B, CRF01_AE and CRF07_BC branches are 
enlarged to better show the phylogenetic relationship among the MSM and non-MSM 
sequences. Sequences from this Beijing MSM cohort, other MSM cohort are indicted by red 
and green, respectively. The MSM sequences from different provinces are indicated with 
different symbols. Non-MSM sequences were shown in black. Other subtypes are indicated 
by blue. MSM sequences from subtype B′ and recombinants (Rec) are indicated by red 
arrows. BJOX35 (B) and BJOX37 (CRF07_BC) that used CCR5, CXCR4 and other 
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coreceptors are indicated by red crosses. Asterisks indicate bootstrap values in which the 
node is supported in 80% or more replicates (out of 1000).
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Figure 2. Estimated timescale of the spread of HIV-1 subtype B, CRF01_AE and CRF07_BC in 
the MSM population
Maximum-clade credibility trees were generated using Tree Annotator v1.5.4 for subtype B 
(A), CRF01_AE (B) and CRF07_BC (C) by Bayesian MCMC approach in BEAST1.5.4. 
The full-length env sequences from the Beijing MSM cohort (red), the MSM cohorts in 
other cities (green), the general population (black) were analyzed. Both strict and relaxed 
(uncorrelated lognormal) molecular clocks were enforced under the GTR and HKY 
nucleotide substitution models 14, respectively, with a gamma-distribution model of among 
site rate heterogeneity (with four rate categories) 15. Each MCMC analysis was run for 20 or 
30 million steps and sampled every 10,000 states. Posterior probabilities were calculated 
with a 10% burn-in and checked for convergence using Tracer v1.5. The maximum clade 
credibility tree was generated using Tree Annotator v1.5.4 available in BEAST and Fig Tree 
1.3.1 was used for visualization of the annotated trees 16. The mean time and 95% highest 
posterior density (HPD) of the most common ancestor (tMRCA: year) areshowed for the key 
nodes based on relaxed (uncorrelated lognormal) molecular clocks under HKY nucleotide 
substitution models in a gamma-distribution of among site rate heterogeneity with four rate 
categories (HKY+Γ4). All posterior probability values for key nodes are 1.0.
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Figure 3. Disparate coreceptor usage of different genotypes
Same amount of the pseudoviruses (500 TCID50) were used to infect NP-2 cell lines 
expressing CD4 and one of the coreceptors. The virus replication was determined by 
measuring p24 concentrations in the culture supernatant three days after infection. The 
coreceptor usage was determined in two independent experiments and data from one 
experiment is shown. The mean and standard error bars are shown for each genotype.
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Figure 4. Neutralization analysis of MSM Env-pseudoviruses against autologous and 
heterologous plasma
(A) Development of autologous neutralizing antibodies. Neutralizing antibody titers in the 
plasma were determined by measuring the luciferase activity in TZM-bl cells. One T/F or 
representative Env pseudovirus from each individual was assayed against autologous 
longitudinal plasmafor CRF01_AE, subtype B and CRF07_BC. (B)Neutralization of Env-
pseudoviruses by genotype-matched and genotype-mismatched plasma. One T/F or 
representative Env pseudovirus from each individual was assayed against genotype-matched 
and genotype-mismatched plasma which had the highest autologous nAb titers. The values 
are the reciprocal plasma dilutions at which luciferase activity was reduced by 50% (ID50) 
relative to no plasma control wells. Red: >1:500; Orange: 1:100-1:500; Green: 1:20-<1:100; 
White: <1:20 or nt (not tested).
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